🇺🇸 FDA
Pipeline program

18F-AV-1451

C19-40

Phase 3 small_molecule active

Quick answer

18F-AV-1451 for Maladie d' Alzheimer, Alzheimer's pathology is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Maladie d' Alzheimer, Alzheimer's pathology
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials